Understanding the Battle Against Heart Disease, Stroke, and Alzheimer's: Insights from Recent Medical Research
Heart disease remains the leading cause of death across various demographics in the United States, with alarming statistics from the CDC highlighting the urgency of the matter: one person dies every 36 seconds due to cardiovascular disease. Strokes follow closely, with an American suffering a stroke every 40 seconds. Alzheimer's disease, the most common cause of dementia among older adults, and affects an estimated 6.2 million Americans, marking it as a leading cause of death for those over 65.
Recent medical focus has shifted towards the role of chronic inflammation in these health issues. Johns Hopkins has indicated that inflammation can exacerbate the growth of arterial plaques, which are central to heart attacks and strokes. Simplifying the complex, when the arterial wall is inflamed, the body's response is to send cholesterol to the site, which, combined with the protein structure fibrin, can form a clot. Cholesterol is a thick, waxy fat and over time calcium deposits can build up. If unresolved, this can lead to arteriosclerosis, characterized by the hardening of arteries due to calcium accumulation.
The discovery of natural substances that support the body's anti-inflammatory responses and fibrin dissolution is a beacon of hope. Serrapeptase, an enzyme identified in the 1980s, has shown promise in reducing post-operative swelling without side effects. Dr. Hansen Nieper even reports life-saving results in using Serrapeptase for severe arterial narrowing, with improvements noted up to 18 months into therapy.
Nattokinase, another enzyme hailing from Japan, has been recognized for its cardiovascular benefits. Studies have shown significant reductions in plaque size and improved blood circulation without adverse effects. Moreover, these enzymes have been linked to potential benefits in Alzheimer's disease management due to their anti-inflammatory and amyloid beta peptide degrading properties.
Vitamins play a crucial role as well. Vitamin D is essential for calcium absorption, influencing bone health and immune system modulation. Vitamin K2 has been found to promote arterial flexibility by preventing calcium accumulation in the arteries.
In light of these findings, Heart Strong Nutraceuticals introduces a patent-pending combination of Serrapeptase and Nattokinase, alongside vitamins D3 and K2, in a unique blend designed to support a healthy body. This all-natural protocol aims to be a cornerstone in the prevention and management of heart disease, stroke, and Alzheimer's.